Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Original Research
The PCSK9 Inhibitors: A Novel Therapeutic Target Enters Clinical Practice
Read More
Perspectives
Employers Engaged in Benefit Design Innovation: Long-Term Trends in a 2015 National Survey
Read More
Original Research
Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid Arthritis
Stakeholder Perspective
You Cannot Manage What You Cannot Measure
Read More
FDA Approvals
,
In the News
FDA Approves First Seasonal Influenza Vaccine Containing an Adjuvant
Read More
FDA Approvals
,
In the News
FDA Approves Bridion to Reverse Effects of Neuromuscular Blocking Drugs Used During Surgery
Read More
FDA Approvals
,
In the News
FDA Approves First Emergency Treatment for Overdose of Certain Types of Chemotherapy
Read More
FDA Approvals
,
In the News
FDA Approves New Oral Therapy to Treat ALK-Positive Lung Cancer
Read More
Mental Health
Faculty Perspectives: Mental Health Services and Emergency Department Use by Patients with Agitation Associated with Schizophrenia or Bipolar Disorder
Read More
FDA Approvals
,
In the News
FDA Approves Empliciti, a New Immune-Stimulating Therapy to Treat Multiple Myeloma
Read More
Faculty Perspectives: Management of Adolescents and Adults with Asthma
Read More
119
120
121
122
123
124
125
Page 122 of 244
Results 1211 - 1220 of 2434